These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 19049901)

  • 61. Blood-brain barrier permeability considerations for CNS-targeted compound library design.
    Hitchcock SA
    Curr Opin Chem Biol; 2008 Jun; 12(3):318-23. PubMed ID: 18435937
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A novel in silico approach to drug discovery via computational intelligence.
    Hecht D; Fogel GB
    J Chem Inf Model; 2009 Apr; 49(4):1105-21. PubMed ID: 19348414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of pharmacologically active metabolites in drug discovery and development.
    Fura A
    Drug Discov Today; 2006 Feb; 11(3-4):133-42. PubMed ID: 16533711
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HAD: an automated database tool for analyzing screening hits in drug discovery.
    Shen J
    J Chem Inf Comput Sci; 2003; 43(5):1668-72. PubMed ID: 14502501
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessment of additive/nonadditive effects in structure-activity relationships: implications for iterative drug design.
    Patel Y; Gillet VJ; Howe T; Pastor J; Oyarzabal J; Willett P
    J Med Chem; 2008 Dec; 51(23):7552-62. PubMed ID: 19012393
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chemical informatics: using molecular shape descriptors in structure-based drug design.
    Jennings A
    Methods Mol Biol; 2012; 841():235-50. PubMed ID: 22222455
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An interesting relationship between drug absorption and melting point.
    Chu KA; Yalkowsky SH
    Int J Pharm; 2009 May; 373(1-2):24-40. PubMed ID: 19429285
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure.
    Leach AG; Jones HD; Cosgrove DA; Kenny PW; Ruston L; MacFaul P; Wood JM; Colclough N; Law B
    J Med Chem; 2006 Nov; 49(23):6672-82. PubMed ID: 17154498
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ask the experts: past, present and future of the rule of five.
    Baell J; Congreve M; Leeson P; Abad-Zapatero C
    Future Med Chem; 2013 May; 5(7):745-52. PubMed ID: 23651089
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Selection of molecules based on shape and electrostatic similarity: proof of concept of "electroforms".
    Jennings A; Tennant M
    J Chem Inf Model; 2007; 47(5):1829-38. PubMed ID: 17824684
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The hidden component of size in two-dimensional fragment descriptors: side effects on sampling in bioactive libraries.
    Dixon SL; Koehler RT
    J Med Chem; 1999 Jul; 42(15):2887-900. PubMed ID: 10425098
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods.
    Houghten RA; Pinilla C; Giulianotti MA; Appel JR; Dooley CT; Nefzi A; Ostresh JM; Yu Y; Maggiora GM; Medina-Franco JL; Brunner D; Schneider J
    J Comb Chem; 2008; 10(1):3-19. PubMed ID: 18067268
    [No Abstract]   [Full Text] [Related]  

  • 74. Use of surface charges from DFT calculations to predict intestinal absorption.
    Jones R; Connolly PC; Klamt A; Diedenhofen M
    J Chem Inf Model; 2005; 45(5):1337-42. PubMed ID: 16180910
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ring systems in mutagenicity databases.
    Kho R; Hodges JA; Hansen MR; Villar HO
    J Med Chem; 2005 Oct; 48(21):6671-8. PubMed ID: 16220983
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
    Edwards PJ; Allart B; Andrews MJ; Clase JA; Menet C
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):425-44. PubMed ID: 16889227
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drugs in other drugs: a new look at drugs as fragments.
    Siegel MG; Vieth M
    Drug Discov Today; 2007 Jan; 12(1-2):71-9. PubMed ID: 17198975
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protein kinase inhibitor-induced endothelial cell cytotoxicity and its prediction based on calculated molecular descriptors.
    Herczenik E; Varga Z; Eros D; Makó V; Oroszlán M; Rugonfalvi-Kiss S; Romics L; Füst G; Kéri G; Orfi L; Cervenak L
    J Recept Signal Transduct Res; 2009; 29(2):75-83. PubMed ID: 19519173
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Leadlikeness and structural diversity of synthetic screening libraries.
    Verheij HJ
    Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.